Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Seoul National University College of Medicine, Seoul, Korea, Republic of (South)

2 abstracts

Abstract
Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results.
Org: Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, Seoul National University College of Medicine, Seoul, Korea, Republic of (South), Cancer Center Clínica Universidad de Navarra, Madrid, Spain, Maria Sklodowska-Curie National Research Institute and Oncology Centre (MSCI), Warsaw, Poland, Hospital Clínico San Carlos and IdISSC, Madrid, Spain,
Abstract
AUTOANTIBODY PRODUCING CD27-CD38INT PRE-NAIVE B CELLS HAVE DEFICIENT CAPACITY TO SUPPORT CD4+ T CELL ACTIVATION IN HEALTHY INDIVIDUALS, BUT EXHIBIT DEFECTIVE FUNCTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Org: Ewha Womans University School of Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South),